Merck KGaA has announced several changes in senior management positions across the group, including the departure of global head of R&D, Annalisa Jenkins. The company did not provide a reason for the loss of Jenkins (pictured), although she recently took up the post of chair of the board of TransCelerate BioPharma. Her role will be taken over on an interim basis by CEO of the company’s Merck Serono division, Belén Garijo, until a permanent successor is found.
Help employers find you! Check out all the jobs and post your resume.
